Korean red ginseng improves vascular stiffness in patients with coronary artery disease

Ick Mo Chung, Joo Weon Lim, Wook Bum Pyun, Hyeyoung Kim

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Korean red ginseng (KRG) has been shown to enhance endothelium-dependent vasorelaxation in experimental animals; however, little is known about its pharmacological effects on vascular stiffness in patients with coronary artery disease (CAD). This randomized, double-blind, placebo-controlled crossover trial was carried out to determine whether KRG has beneficial effects on arterial stiffness, cardiovascular risk factors such as plasma lipid profiles and blood pressure (BP), and Rhoassociated kinase (ROCK) activity. Twenty patients (mean age, 62.5 years) with stable angina pectoris were given KRG (2.7 g/day) and a placebo alternatively for 10 weeks. Blood biochemical analysis and pulse wave velocity (PWV) recording were performed on day 0 and after the completion of each treatment. ROCK activity was assessed based on the level of phospho-Thr853 in the myosin-binding subunit of myosin light chain phosphatase, determined by Western blot analysis of peripheral blood mononuclear cells. KRG significantly decreased the systolic BP, brachial ankle PWV, and heart femoral PWV in the patients (all p < 0.05), but did not significantly alter the serum lipid profles, including triglycerides and total, high-density lipoprotein, and low-density lipoprotein cholesterol levels. The ROCK activity tended to decrease (p = 0.068) following KRG treatment. The placebo did not significantly alter any of the variables. In conclusion, KRG decreased systolic BP and arterial stiffness, probably via the inhibition of ROCK activity, in patients with CAD, but had a neutral effect on serum lipid profiles. Our data suggest that KRG has a therapeutic effect on CAD.

Original languageEnglish
Pages (from-to)212-218
Number of pages7
JournalJournal of Ginseng Research
Volume34
Issue number3
DOIs
Publication statusPublished - 2010 Dec 1

Fingerprint

Vascular Stiffness
Panax
Coronary Artery Disease
Blood pressure
Phosphotransferases
Stiffness
Pulse Wave Analysis
Lipids
Blood Pressure
Blood
Myosin-Light-Chain Phosphatase
Placebos
HDL Lipoproteins
Myosins
LDL Cholesterol
Animals
Triglycerides
Stable Angina
Plasmas
Therapeutic Uses

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Complementary and alternative medicine

Cite this

Chung, Ick Mo ; Lim, Joo Weon ; Pyun, Wook Bum ; Kim, Hyeyoung. / Korean red ginseng improves vascular stiffness in patients with coronary artery disease. In: Journal of Ginseng Research. 2010 ; Vol. 34, No. 3. pp. 212-218.
@article{e66da7e269a4477bb7f3a920a3453426,
title = "Korean red ginseng improves vascular stiffness in patients with coronary artery disease",
abstract = "Korean red ginseng (KRG) has been shown to enhance endothelium-dependent vasorelaxation in experimental animals; however, little is known about its pharmacological effects on vascular stiffness in patients with coronary artery disease (CAD). This randomized, double-blind, placebo-controlled crossover trial was carried out to determine whether KRG has beneficial effects on arterial stiffness, cardiovascular risk factors such as plasma lipid profiles and blood pressure (BP), and Rhoassociated kinase (ROCK) activity. Twenty patients (mean age, 62.5 years) with stable angina pectoris were given KRG (2.7 g/day) and a placebo alternatively for 10 weeks. Blood biochemical analysis and pulse wave velocity (PWV) recording were performed on day 0 and after the completion of each treatment. ROCK activity was assessed based on the level of phospho-Thr853 in the myosin-binding subunit of myosin light chain phosphatase, determined by Western blot analysis of peripheral blood mononuclear cells. KRG significantly decreased the systolic BP, brachial ankle PWV, and heart femoral PWV in the patients (all p < 0.05), but did not significantly alter the serum lipid profles, including triglycerides and total, high-density lipoprotein, and low-density lipoprotein cholesterol levels. The ROCK activity tended to decrease (p = 0.068) following KRG treatment. The placebo did not significantly alter any of the variables. In conclusion, KRG decreased systolic BP and arterial stiffness, probably via the inhibition of ROCK activity, in patients with CAD, but had a neutral effect on serum lipid profiles. Our data suggest that KRG has a therapeutic effect on CAD.",
author = "Chung, {Ick Mo} and Lim, {Joo Weon} and Pyun, {Wook Bum} and Hyeyoung Kim",
year = "2010",
month = "12",
day = "1",
doi = "10.5142/jgr.2010.34.3.212",
language = "English",
volume = "34",
pages = "212--218",
journal = "Journal of Ginseng Research",
issn = "1226-8453",
publisher = "The Korean Society of Ginseng",
number = "3",

}

Korean red ginseng improves vascular stiffness in patients with coronary artery disease. / Chung, Ick Mo; Lim, Joo Weon; Pyun, Wook Bum; Kim, Hyeyoung.

In: Journal of Ginseng Research, Vol. 34, No. 3, 01.12.2010, p. 212-218.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Korean red ginseng improves vascular stiffness in patients with coronary artery disease

AU - Chung, Ick Mo

AU - Lim, Joo Weon

AU - Pyun, Wook Bum

AU - Kim, Hyeyoung

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Korean red ginseng (KRG) has been shown to enhance endothelium-dependent vasorelaxation in experimental animals; however, little is known about its pharmacological effects on vascular stiffness in patients with coronary artery disease (CAD). This randomized, double-blind, placebo-controlled crossover trial was carried out to determine whether KRG has beneficial effects on arterial stiffness, cardiovascular risk factors such as plasma lipid profiles and blood pressure (BP), and Rhoassociated kinase (ROCK) activity. Twenty patients (mean age, 62.5 years) with stable angina pectoris were given KRG (2.7 g/day) and a placebo alternatively for 10 weeks. Blood biochemical analysis and pulse wave velocity (PWV) recording were performed on day 0 and after the completion of each treatment. ROCK activity was assessed based on the level of phospho-Thr853 in the myosin-binding subunit of myosin light chain phosphatase, determined by Western blot analysis of peripheral blood mononuclear cells. KRG significantly decreased the systolic BP, brachial ankle PWV, and heart femoral PWV in the patients (all p < 0.05), but did not significantly alter the serum lipid profles, including triglycerides and total, high-density lipoprotein, and low-density lipoprotein cholesterol levels. The ROCK activity tended to decrease (p = 0.068) following KRG treatment. The placebo did not significantly alter any of the variables. In conclusion, KRG decreased systolic BP and arterial stiffness, probably via the inhibition of ROCK activity, in patients with CAD, but had a neutral effect on serum lipid profiles. Our data suggest that KRG has a therapeutic effect on CAD.

AB - Korean red ginseng (KRG) has been shown to enhance endothelium-dependent vasorelaxation in experimental animals; however, little is known about its pharmacological effects on vascular stiffness in patients with coronary artery disease (CAD). This randomized, double-blind, placebo-controlled crossover trial was carried out to determine whether KRG has beneficial effects on arterial stiffness, cardiovascular risk factors such as plasma lipid profiles and blood pressure (BP), and Rhoassociated kinase (ROCK) activity. Twenty patients (mean age, 62.5 years) with stable angina pectoris were given KRG (2.7 g/day) and a placebo alternatively for 10 weeks. Blood biochemical analysis and pulse wave velocity (PWV) recording were performed on day 0 and after the completion of each treatment. ROCK activity was assessed based on the level of phospho-Thr853 in the myosin-binding subunit of myosin light chain phosphatase, determined by Western blot analysis of peripheral blood mononuclear cells. KRG significantly decreased the systolic BP, brachial ankle PWV, and heart femoral PWV in the patients (all p < 0.05), but did not significantly alter the serum lipid profles, including triglycerides and total, high-density lipoprotein, and low-density lipoprotein cholesterol levels. The ROCK activity tended to decrease (p = 0.068) following KRG treatment. The placebo did not significantly alter any of the variables. In conclusion, KRG decreased systolic BP and arterial stiffness, probably via the inhibition of ROCK activity, in patients with CAD, but had a neutral effect on serum lipid profiles. Our data suggest that KRG has a therapeutic effect on CAD.

UR - http://www.scopus.com/inward/record.url?scp=79951798866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951798866&partnerID=8YFLogxK

U2 - 10.5142/jgr.2010.34.3.212

DO - 10.5142/jgr.2010.34.3.212

M3 - Article

AN - SCOPUS:79951798866

VL - 34

SP - 212

EP - 218

JO - Journal of Ginseng Research

JF - Journal of Ginseng Research

SN - 1226-8453

IS - 3

ER -